Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 10/20 | 0.72 |
| ▸ | CHRNA4 | P43681 | 10/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | JAK2 | O60674 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3055695 | 0.84 | CHRNB2 (1.00) | CHRNB2CHRNA4 | |
| SCHEMBL3055492 | 0.83 | CHRNB2 (1.00) | CHRNB2CHRNA4KDM4E | |
| SCHEMBL4822010 | 0.79 | CHRNB2 (0.56) | CHRNB2CHRNA4ALDH1A1MAPTGAA | |
| SCHEMBL4827877 | 0.79 | CHRNB2 (0.56) | CHRNB2CHRNA4ALDH1A1MAPTGAA | |
| SCHEMBL31195844 | 0.79 | CHRNB2 (0.48) | CHRNB2CHRNA4ALDH1A1MAPTGAA | |
| SCHEMBL7193385 | 0.79 | CHRNB2 (0.72) | CHRNB2CHRNA4ALDH1A1MAPTGAA | |
| SCHEMBL30811705 | 0.76 | CHRNB2 (0.49) | CHRNB2CHRNA4MAPTKDM4E | |
| SCHEMBL30811838 | 0.76 | CHRNB2 (0.49) | CHRNB2CHRNA4MAPTKDM4E | |
| SCHEMBL25889360 | 0.76 | CHRNB2 (0.46) | CHRNB2CHRNA4MAPTKDM4E | |
| SCHEMBL4821233 | 0.76 | CHRNB2 (0.52) | CHRNB2CHRNA4ALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1178982-A1 | HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS | ABBOTT LABORATORIES (US) | 2002-02-13 | — | — | EP | disclosed |
| WO-2000071534-A1 | HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS | ABBOTT LABORATORIES (US) | 2000-11-30 | — | — | WO | disclosed |